Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Adheron Therapeutics
is defunct.
Bought by Roche, Oct 2015, $105M + $475 Milestones
------------------
If you believe any of this information is incorrect, please
let us know
.